GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Shinyak Corp (XKRX:067290) » Definitions » Cyclically Adjusted Revenue per Share

JW Shinyak (XKRX:067290) Cyclically Adjusted Revenue per Share : ₩2,153.95 (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is JW Shinyak Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

JW Shinyak's adjusted revenue per share for the three months ended in Dec. 2023 was ₩597.654. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩2,153.95 for the trailing ten years ended in Dec. 2023.

During the past 12 months, JW Shinyak's average Cyclically Adjusted Revenue Growth Rate was 5.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of JW Shinyak was 6.00% per year. The lowest was -0.20% per year. And the median was 3.80% per year.

As of today (2024-05-19), JW Shinyak's current stock price is ₩1855.00. JW Shinyak's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₩2,153.95. JW Shinyak's Cyclically Adjusted PS Ratio of today is 0.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of JW Shinyak was 5.68. The lowest was 0.82. And the median was 2.33.


JW Shinyak Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for JW Shinyak's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Shinyak Cyclically Adjusted Revenue per Share Chart

JW Shinyak Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,745.60 1,808.74 1,913.24 2,043.80 2,153.95

JW Shinyak Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,043.80 2,077.44 2,097.84 2,142.91 2,153.95

Competitive Comparison of JW Shinyak's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, JW Shinyak's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Shinyak's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Shinyak's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JW Shinyak's Cyclically Adjusted PS Ratio falls into.



JW Shinyak Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JW Shinyak's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=597.654/118.8477*118.8477
=597.654

Current CPI (Dec. 2023) = 118.8477.

JW Shinyak Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 364.895 99.253 436.933
201406 384.891 99.353 460.413
201409 396.141 99.608 472.657
201412 537.331 99.098 644.418
201503 402.338 99.720 479.512
201506 415.030 100.050 493.007
201509 393.680 100.110 467.366
201512 512.487 100.220 607.742
201603 444.254 100.560 525.045
201606 455.426 100.790 537.021
201609 454.435 101.460 532.314
201612 432.485 101.560 506.103
201703 438.245 102.850 506.411
201706 354.809 102.610 410.956
201709 456.668 103.490 524.437
201712 340.064 102.990 392.425
201803 494.404 104.100 564.446
201806 437.560 104.130 499.405
201809 439.897 105.650 494.849
201812 487.486 104.350 555.214
201903 455.013 104.490 517.535
201906 513.324 104.880 581.687
201909 539.557 105.200 609.554
201912 550.888 105.120 622.829
202003 468.758 105.540 527.864
202006 565.117 104.870 640.439
202009 567.611 106.200 635.210
202012 607.921 105.765 683.116
202103 478.553 107.357 529.773
202106 465.995 107.579 514.809
202109 524.913 108.759 573.604
202112 633.935 109.676 686.946
202203 511.904 111.806 544.145
202206 398.934 114.083 415.596
202209 505.379 114.831 523.055
202212 593.065 115.200 611.843
202303 514.644 116.550 524.792
202306 534.028 117.140 541.814
202309 547.733 119.111 546.521
202312 597.654 118.848 597.654

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


JW Shinyak  (XKRX:067290) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

JW Shinyak's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1855.00/2153.95
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of JW Shinyak was 5.68. The lowest was 0.82. And the median was 2.33.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


JW Shinyak Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of JW Shinyak's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Shinyak (XKRX:067290) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2477, Nambusunhwan-ro, Seocho-gu, Seoul, KOR, 137-864
JW Shinyak Corp is a pharmaceutical company. The company produces and provides high-quality medicine and medical supplies needed in dermatology, urology, pediatrics, otolaryngology. The key products include antibiotics, anesthetics, respiratory drugs, urology drugs, cardiovascular drugs, allergy drugs, digestive drugs, anti-inflammatory drugs, antivirals as well as cosmetic products including creams, cleansers, toners, essences, lotions, among others.

JW Shinyak (XKRX:067290) Headlines

No Headlines